Form 4: Teladoc Health Executive Sells Shares After Vesting of Stock Units
SEC Form 4 Filing
A Teladoc Health executive, Kelly Bliss, sold 2,040 shares of common stock after the vesting of performance and restricted stock units.
Summary
- Kelly Bliss, President of U.S. Group Health at Teladoc Health, Inc., reported transactions involving the company's stock.
- On November 29, 2024, Bliss acquired 1,189 shares through the vesting of performance stock units, 1,404 shares through the vesting of restricted stock units granted in 2022, and 3,488 shares through the vesting of restricted stock units granted in 2023.
- On December 2, 2024, Bliss sold 2,040 shares at a price of $11.927 per share.
- The sales were to cover tax withholding obligations related to the vesting of the stock units.
- Following these transactions, Bliss directly owns 32,244 shares of Teladoc Health common stock.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and does not indicate any positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly traded companies, particularly around vesting dates.
- The sale of shares to cover tax obligations is a standard practice.
- The vesting schedules described are typical for equity compensation plans.
Stakeholder Impact
- The sale of shares by an executive may have a minor impact on shareholder sentiment, but is generally considered a normal part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 2022-03-01 | Date of grant of 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 2023-03-03 | Date of grant of 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 2024-03-01 | Date the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 2024-11-29 | Date of acquisition of shares through vesting of performance and restricted stock units. |
| 2024-12-02 | Date of sale of 2,040 shares. |
| 2024-12-03 | Date of filing of the Form 4. |
Keywords
Teladoc Health, stock sale, insider trading, stock units, vesting, executive, TDOC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.